Over the past 5 years, Connecticut has led nationwide efforts to secure more than $50 billion nationwide to combat the opioid epidemic, including $600 million for Connecticut alone to support treatment, prevention, and recovery. That money has begun to flow. Connecticut’s Opioid Settlement Advisory Committee, comprised of health professionals, individuals with lived experience, and state and municipal leaders is responsible for allocating and accounting for opioid settlement funds. Here’s more information on each case.

WATCH: Attorney General Tong testifies to U.S. House committee on Sackler family abuse of bankruptcy laws

Summary of Key Cases

Publicis: In February 2024, Attorney General Tong announced a $350 million national settlement with Publicis Health to resolve investigations into the global marketing and communications firm’s role in the prescription opioid crisis.

Walmart: In November 2022, Attorney General Tong announced Connecticut had reached a $3.1 billion agreement with Walmart to resolve allegations that the company contributed to the opioid addiction crisis by failing to appropriately oversee the dispensing of opioids at its stores. 

CVS and Walgreens: In December 2022, Attorney General Tong announced a $10.7 billion agreement with CVS and Walgreens.

Endo: In August 2022, Attorney General Tong announced an agreement in principle with opioid maker Endo International and its lenders that would provide up to $450 million to participating states and local governments for treatment and prevention, ban promotion of Endo’s opioids, and require Endo to turn over millions of documents related to its role in the opioid crisis for publication in a public online archive.

Allergan: In July 2022, Attorney General Tong announced a $2.37 billion agreement framework with Allergan and states regarding the generic drug manufacturer’s role in the opioid epidemic.

Teva: In July 2022, Attorney General Tong announced a $4.25 billion agreement framework with Teva Pharmaceuticals and states regarding the generic drug manufacturer’s role in the opioid epidemic.

Purdue Pharma and the Sacklers: Attorney General Tong announced in March 2022 that Purdue Pharma and the Sackler family will pay $6 billion to victims, survivors, and states for their role in the opioid epidemic. Connecticut will receive up to $95 million to support opioid treatment and prevention and provide aid to victims and survivors. The U.S. Supreme Court is currently deciding whether to uphold the bankruptcy plan for Purdue Pharma over concerns about the protections from civil lawsuits that the plan grants the Sacklers.

Distributors and Johnson & Johnson: In July 2021, Attorney General Tong announced an historic $26 billion agreement with pharmaceutical distributors Cardinal, McKesson, and AmerisourceBergen and manufacturer Johnson & Johnson to bring desperately needed resources to fight the opioid crisis. Connecticut will receive approximately $300 million as part of the landmark settlement.

McKinsey: In February 2021, Attorney General Tong announced Connecticut had helped lead a coalition of attorneys general from 47 states, the District of Columbia and five U.S. territories in a $573 million settlement with McKinsey & Company. Connecticut will receive $7,513,087.22, which will be used to abate the opioid epidemic.

Mallinckrodt: In October 2020, Attorney General Tong announced a $1.6 billion global settlement framework had been reached between state attorneys general and opioid manufacturer Mallinckrodt. The company has since declared bankruptcy. Connecticut will receive $13.9 million.